Nguyen Elaine, Wright Melanie, Holmes John, Cleveland Kevin, Oliphant Catherine, Nies Mary, Robinson Renee
Department of Pharmacy Practice and Administration, College of Pharmacy, Idaho State University, Meridian, ID, United States.
Department of Pharmacy Practice and Administration, College of Pharmacy, Idaho State University, Pocatello, ID, United States.
JMIR Form Res. 2022 Dec 1;6(12):e39109. doi: 10.2196/39109.
Vaccination remains one of the most effective ways to limit the spread of infectious diseases such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19. Unfortunately, vaccination hesitancy continues to be a threat to national and global health. Further research is necessary to determine the modifiable and nonmodifiable factors contributing to COVID-19 vaccine hesitancy in under-resourced, underserved, and at-risk rural and urban communities.
This study aimed to identify, understand, and address modifiable barriers and factors contributing to COVID-19 vaccine hesitancy among vaccine-eligible individuals with access to the vaccine in Alaska and Idaho.
An electronic survey based on the World Health Organization (WHO) Strategic Advisory Group on Experts (SAGE) on Immunization survey tool and investigators' previous work was created and distributed in June 2021 and July 2021. To be eligible to participate in the survey, individuals had to be ≥18 years of age and reside in Alaska or Idaho. Responses were grouped into 4 mutually exclusive cohorts for data analysis and reporting based on intentions to be vaccinated. Respondent characteristics and vaccine influences between cohorts were compared using Chi-square tests and ANOVA. Descriptive statistics were also used.
There were data from 736 usable surveys with 40 respondents who did not intend to be vaccinated, 27 unsure of their intentions, 8 who intended to be fully vaccinated with no doses received, and 661 fully vaccinated or who intended to be vaccinated with 1 dose received. There were significant differences in characteristics and influences between those who were COVID-19 vaccine-hesitant and those who had been vaccinated. Concerns related to possible side effects, enough information on long-term side effects, and enough information that is specific to the respondent's health conditions were seen in those who did not intend to be fully vaccinated and unsure about vaccination. In all cohorts except those who did not intend to be fully vaccinated, more information about how well the vaccine works was a likely facilitator to vaccination.
These survey results from 2 rural states indicate that recognition of individual characteristics may influence vaccine choices. However, these individual characteristics represent only a starting point to delivering tailored messages that should come from trusted sources to address vaccination barriers.
接种疫苗仍然是限制传染病传播的最有效方法之一,例如由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染病,该病毒是导致COVID-19的病原体。不幸的是,疫苗犹豫仍然对国家和全球健康构成威胁。有必要进行进一步研究,以确定导致资源匮乏、服务不足以及处于风险中的农村和城市社区对COVID-19疫苗犹豫的可改变和不可改变因素。
本研究旨在识别、理解并解决阿拉斯加和爱达荷州有资格接种疫苗且能够获得疫苗的个体中,导致对COVID-19疫苗犹豫的可改变障碍和因素。
基于世界卫生组织(WHO)免疫战略咨询专家组(SAGE)的调查工具以及研究人员之前的工作,创建了一份电子调查问卷,并于2021年6月和2021年7月进行分发。要符合参与调查的条件,个体必须年满18岁且居住在阿拉斯加或爱达荷州。根据接种意愿,将回答分为4个相互排斥的队列进行数据分析和报告。使用卡方检验和方差分析比较各队列之间的受访者特征和疫苗影响因素。同时也采用了描述性统计方法。
共有736份可用调查问卷的数据,其中40名受访者不打算接种疫苗,27名不确定自己的意愿,8名打算全程接种但尚未接种任何剂量,661名已全程接种或打算接种1剂。对COVID-19疫苗犹豫的人群和已接种疫苗的人群在特征和影响因素方面存在显著差异。在不打算全程接种以及对接种不确定的人群中,存在对可能的副作用、关于长期副作用的足够信息以及针对受访者健康状况的足够特定信息的担忧。在除不打算全程接种的所有队列中,更多关于疫苗效果的信息可能是接种疫苗的促进因素。
这两个农村州的调查结果表明,认识个体特征可能会影响疫苗选择。然而,这些个体特征只是提供量身定制信息的起点,这些信息应该来自可信赖的来源,以解决接种疫苗的障碍。